Perioperative reduction of the warfarin dose [2]

American Journal of Medicine

Volumn 115, Issue 9, 2003, Pages 741-742

  Milligan, Paul E ^a   Banet, Gerald A ^a   Gage, Brian F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL STANDARD UNIT; LETTER; LINEAR REGRESSION ANALYSIS; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

EID: 0346157350     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.06.002     Document Type: Letter

References (9)

1. White R.H., McKittrick T., Hutchinson R., Twitchell J. Temporary discontinuation of warfarin therapy Changes in the International Normalized Ratio . Ann Intern Med. 122:1995;40-42.
2. Palareti G., Legnani C., Guazzaloca G., et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thromb Haemost. 72:1994;222-226.
3. Eckman M.H., Beshansky J.R., Durand-Zaleski I., et al. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Does low risk mean high cost? JAMA. 263:1990;1513-1521.
4. Spandorfer J.M., Lynch S., Weitz H.H., et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol. 84:1999;478-480.
5. Berge E., Abdelnoor M., Nakstad P.H., Sandset P.M. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial . Lancet. 355:2000;1205-1210.
6. Hirsh J., Fuster V., Ansell J., Halperin J.L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 107:2003;1692-1711.
7. Marietta M., Bertesi M., Simoni L., et al. A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery. Clin Lab Haematol. 25:2003;127-130.
8. Hylek E.M., Regan S., Go A.S., et al. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 135:2001;393-400.
9. Rogers J.F., Nafziger A.N., Bertino J.S. Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med. 113:2002;746-750.